2021-01-06,PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2021-01-05,PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
2020-12-21,PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19 Vaccine
2020-12-09,PDS Biotechnology Appoints Seth Van Voorhees as Chief Financial Officer
2020-11-27,Where Do Hedge Funds Stand On PDS Biotechnology Corporation (PDSB)?
2020-11-16,PDS Biotech Announces New and Broad Versamune® Platform Patent Claims
2020-11-13,PDS Biotech to Present at the Virtual Fall Investor Summit on November 16th-18th
2020-11-12,PDS Biotechnology Corp. to Host Earnings Call
2020-11-11,PDS Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update
2020-11-10,PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine
2020-11-09,PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with Merck
2020-11-05,"PDS Biotechnology Appoints Renowned Oncologist Otis Brawley, M.D. to its Board of Directors"
2020-10-29,PDS Biotechnology Announces Feature in Grand Rounds Webinar hosted by Alliance Global Partners and Conference Call and Webcast for Third Quarter 2020 Financial Results
2020-10-26,PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 in Combination with Standard of Care Chemoradiotherapy in Advanced Cervical Cancer
2020-10-01,PDS Biotechnology Announces Participation in Noble Capital Markets Virtual Road Show Series
2020-09-28,PDS Biotechnology to Present Results from its Phase 1 Trial of PDS0101 and the Phase 2 Clinical Strategy in Patients with Advanced HPV-Associated Malignancies
2020-09-08,PDS Biotechnology to Participate in Upcoming Healthcare Investor Conferences
2020-08-31,PDS Biotechnology Announces Participation in Noble Capital Markets C-Suite Interview Series
2020-08-13,PDS Biotechnology Corporation Announces Closing of Approx. $19 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
2020-08-13,PDS Biotechnology Reports Financial Results for the Second Quarter 2020 and Provides Business Update
2020-08-11,PDS Biotechnology Corporation Announces Pricing of $16.5 Million Public Offering of Common Stock
2020-08-10,PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock
2020-08-06,3 Strong Buy Healthcare Stocks Under $5 That Could See Outsized Gains
2020-07-30,PDS Biotechnology Announces Conference Call and Webcast for Second Quarter 2020 Financial Results
2020-07-27,"PDS Biotech Announces Preclinical Data for PDS0203, a T-Cell Activating Recombinant Protein Vaccine Against COVID-19"
2020-07-14,PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine
2020-06-22,PDS Biotech Announces Publication of Preclinical Results of PDS0101 Combination by the National Cancer Institute in the Journal for ImmunoTherapy of Cancer
2020-06-17,PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine
2020-06-15,PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 Led by the National Cancer Institute
2020-06-14,Wall Street Suggests Buying These 2 Falling Knives
2020-06-05,"The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid"
2020-06-04,"PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in Advanced Cervical Cancer"
2020-06-03,47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
2020-06-02,PDS Biotechnology to Present at the 2020 Virtual Investor Summit
2020-05-13,PDS Biotechnology Announces Publication at American Society of Clinical Oncology (ASCO) 2020
2020-05-13,PDS Biotechnology Reports Financial Results for the First Quarter 2020 and Provides Business Update
2020-05-04,PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2020 Financial Results
2020-04-30,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1"
2020-04-29,PDS Biotechnology Expands CRADA with the National Cancer Institute to Include Second Versamune®-Based Anti-Cancer Product
2020-04-16,PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002 trial
2020-04-09,PDS Biotechnology Appoints Dr. Ilian Iliev to Board of Directors
2020-04-02,PDS Biotechnology (PDSB) Upgraded to Buy: What Does It Mean for the Stock?
2020-03-27,PDS Biotechnology Reports Full Year 2019 Financial Results and Provides Business Update
2020-03-23,PDS Biotechnology Announces Resignation of Andrew Saik as CFO
2020-03-05,PDS Biotechnology Expands Patent Portfolio for its Novel Versamune® Platform
2020-02-27,PDS Biotechnology Announces Commencement of Work Under a Pre-Clinical Collaboration with Farmacore Biotechnology for Tuberculosis
2020-02-24,"PDS Biotechnology Appoints Kamil Ali-Jackson, Esq. to Board of Directors"
2020-02-17,PDS Biotechnology to Present at Noble Capital Markets' 16th Annual Small & Microcap Investor Conference
2020-02-14,PDS Biotechnology Corporation Announces Closing of Public Offering
2020-02-12,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data"
2020-02-11,PDS Biotechnology Corporation Announces Pricing of Public Offering of Approximately $12 Million of Shares of Common Stock
2020-02-05,PDS Biotechnology to Present at the 2020 BIO CEO & Investor Conference
2019-12-11,PDS Biotechnology Announces Principal Investigator and Independent Data Monitoring Committee for its Phase 2 Clinical Collaboration with Merck
2019-12-11,PDS Biotechnology Announces Resignation of James Loughlin from Board of Directors
2019-12-03,PDS Biotechnology to Present at the 12th Annual LD Micro Main Event
2019-11-25,PDS Biotechnology to Present at the World Vaccine & Immunotherapy Congress West Coast 2019
2019-11-13,PDS Biotechnology (NASDAQ:PDSB) Will Have To Spend Its Cash Wisely
2019-11-07,PDS Biotechnology Reports Third Quarter 2019 Financial Results and Provides Business Update
2019-11-06,PDS Biotechnology Accepted for Oral Presentation at the 34th Annual Society for Immunotherapy of Cancer Annual Meeting
2019-10-22,PDS Biotechnology Completes Manufacturing of Clinical Batches of PDS0101
2019-10-03,What's Behind PDS Biotech's Rally?
2019-10-03,PDS Biotechnology Corp. Announces Clinical Collaboration with Merck
2019-10-01,PDS Biotechnology Prioritizes Development of PDS0101 in Advanced Cancers Following Promising Phase 1 Clinical Outcome Data
2019-09-19,PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human Trial
2019-09-03,PDS Biotechnology to Present at the 21st Annual H.C. Wainwright Global Investment Conference
2019-08-01,PDS Biotechnology Reports Second Quarter 2019 Financial Results And Provides Business Update
2019-07-03,PDS Biotechnology Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2019-06-19,PDS Biotechnology Corporation Granted U.S. and European Patents for Versamune® - GM-CSF Combination to Overcome Tumor Immune Suppression
2019-05-29,Does PDS Biotechnology Corporation (NASDAQ:PDSB) Create Value For Shareholders?
2019-05-29,PDS Biotechnology Signs Cooperative Research and Development Agreement with National Cancer Institute to Perform a Phase 2 Clinical Study of PDS0101 in Combination with Other Immune-modulating Agents in Advanced HPV-related Cancers
2019-05-28,PDS Biotechnology to Present at the 9th Annual LD Micro Invitational
2019-05-17,Learning When To Pick Your Battles Starts With Winning Setups
2019-05-15,PDS Biotechnology Announces Publication Supporting Novel Mechanisms of Action of its Proprietary Versamune® Platform in Cancer Immunotherapy
2019-05-14,PDS Biotechnology: 1Q Earnings Snapshot
2019-05-14,PDS Biotechnology Reports First Quarter 2019 Financial Results and Provides Business Update
2019-04-08,PDS Biotechnology Appoints Stephen Glover to its Board of Directors
